Such decision making underscores broad ethical concerns about health equity, the allocation of scarce resources, and the prioritization of patient populations most in need
Many patients continue using Tirzepatide at a lower dosage to prevent weight regain
Acknowledgements This work was supported by grants from the National Natural Science Foundation of China to YL (No
The different results in fasting blood glucose levels compared to our study may be due to the fact that participants in the Grabez study [18] had diabetes and were receiving routine and long-term metformin therapy, as well as the lack of dietary recommendations in that study
00:00:11 Narrator On this episode, Associate Editor and Clinical Pharmacist Vickie Danaher reviews how the new oral version of semaglutide is changing how clinicians think about GLP1 medications for weight loss
Its impossible to know for sure what makes one patient lose more than another but certainly diet, exercise and avoiding high carb and highly refined sugars helps